McKesson UK

Coventry, United Kingdom Founded: 1833 • Age: 193 yrs Acquired By Aurelius UK
Pharmaceutical drugs are manufactured by McKesson in the United Kingdom.

About McKesson UK

McKesson UK is a Healthcare company based in Coventry (United Kingdom) founded in 1833, and was acquired by Aurelius UK in November 2021. Pharmaceutical drugs are manufactured by McKesson in the United Kingdom. Its chief executive, as recorded, is Toby Anderson. Its focus areas include Traditional Pharmaceuticals.

Company details

McKesson was founded in 1833 and is headquartered in Coventry, United Kingdom. Operations focus on the pharmaceutical sector, where generic and branded drugs are produced for healthcare markets. Supply chain management and distribution services for medical products are handled across the region. The company is led by CEO Toby Anderson, with activities centered on regulatory-compliant manufacturing processes.

  • Headquarters Coventry, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mckesson.uk
  • Social LinkedIn X
  • Acquired by Aurelius UK (Nov 2021)
Key Metrics

Investors in McKesson UK

McKesson UK has secured backing from 1 investor. Prominent investors backing the company include AURELIUS.

All
InvestorDescriptionFounded YearDomainLocation
AURELIUS is recognized as a globally active alternative investor.
aureliusinvest.co.uk
Premium access

Investor details for McKesson UK

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of McKesson UK

1 people are tracked at McKesson UK (1 in leadership).

NameRoleGroup
Toby Anderson
CEOLeadership
Premium access

Complete people profiles for McKesson UK

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of McKesson UK

2 dated milestones of McKesson UK across 188 years, from founding to its latest funding, stage changes and deals.

  1. Founded McKesson UK is founded.
  2. Exit Acquired by Aurelius UK.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about McKesson UK

McKesson UK was founded in 1833.

McKesson UK is headquartered in Coventry, United Kingdom.

Toby Anderson is the CEO of McKesson UK, as recorded in our data.

McKesson was founded in 1833 and is headquartered in Coventry, United Kingdom. Operations focus on the pharmaceutical sector, where generic and branded drugs are produced for healthcare markets. Supply chain management and distribution services for medical products are handled across the region. The company is led by CEO Toby Anderson, with activities centered on regulatory-compliant manufacturing processes.

McKesson UK has 1 investor. Key investors include AURELIUS.

Yes. McKesson UK was acquired by Aurelius UK in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available